Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 3.1 EX-3.1
- 3.2 EX-3.2
- 3.3 EX-3.3
- 10.7 EX-10.7
- 21.2 EX-21.2
- 23.1 EX-23.1
- 23.2 EX-23.2
- 99.4 EX-99.4
- 99.5 EX-99.5
- 99.6 EX-99.6
- 99.7 EX-99.7
- 99.8 EX-99.8
- 99.9 EX-99.9
- 99.10 EX-99.10
- EX-FILING FEES Ex-filing Fees
- Download Excel data file
- View Excel data file
Associated filings
- 2 Aug 23 EFFECT Notice of effectiveness
- 1 Aug 23 424B3 Prospectus supplement
- 31 Jul 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 17 Jul 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 22 Jun 23 S-4/A Registration of securities issued in business combination transactions (amended)
-
15 May 23 S-4 Registration of securities issued in business combination transactions
DNTH similar filings
- 31 Jul 23 Registration of securities issued in business combination transactions (amended)
- 17 Jul 23 Registration of securities issued in business combination transactions (amended)
- 22 Jun 23 Registration of securities issued in business combination transactions (amended)
- 15 May 23 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement on Form S-4 of our report dated May 15, 2023, relating to the financial statements of Dianthus Therapeutics, Inc. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Deloitte & Touche LLP
Morristown, New Jersey
May 15, 2023